News
Abbisko Therapeutics completes first patient dosing in registrational study of irpagratinib to treat treatment of hepatocellular carcinoma: Shanghai Tuesday, June 17, 2025, 18:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback